Title: 594: Abiraterone Acetate, an Oral Irreversible Inhibitor of CYP450C17, Administered to Castration Refractory Prostate Cancer Patients is Safe, Suppresses Androgen and Steroid Precursor Levels, and has a High Degree of Durable Antitumor Activity